CME Information
Overview
Provider Statement
This continuing medical education activity is provided by 
Support Statement
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Target Audience
The intended audience for this activity is ophthalmologists, neuro-ophthalmologists, neurologists, optometrists, and other health care professionals involved in the management of patients with neuromyelitis optica spectrum disorder.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Utilize evidence-based diagnostic criteria to improve the early detection of NMOSD.
- Differentiate current NMOSD therapeutics based on their mechanisms of action, efficacy, safety, and administration.
- Incorporate therapeutic regimens for the treatment of NMOSD based on their safety and efficacy, as well as their ability to control acute attacks and prevent future relapses.
Activity Chair
Prem S. Subramanian, MD, PhD
Professor of Ophthalmology, Neurology, and Neurosurgery
University of Colorado School of Medicine
Vice Chair for Academic Affairs
Division Head, Neuro-Ophthalmology
University of Colorado Sue Anschutz-Rodgers Eye Center
Aurora, CO
Faculty
Michael S. Lee, MD
Professor, Departments of Ophthalmology and Visual Neurosciences, Neurosurgery, and Neurology
Mackall-Scheie Research Chair
Director, Ophthalmology Residency Program
Director, Neuro-Ophthalmology Service
University of Minnesota
Minneapolis, MN
Brian G. Weinshenker, MD, FRCP(C), FAAN
Professor of Neurology
Alix School of Medicine, Mayo Clinic
Rochester, MN
Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.
Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn credits equivalent to the amount of CME credits claimed for the activity.
This enduring material is approved for 1 year from the date of original release, January 25, 2022, to January 24, 2023.
How to Participate in This Activity and Obtain CME Credit
To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Activity Chair and Faculty report the following relevant financial relationship(s)
Michael S. Lee, MD
Advisor: Horizon
Individual Stocks or Stock Options: Horizon
Prem S. Subramanian, MD, PhD
Consultant: Horizon
Independent Research Contractor: Horizon
Brian G. Weinshenker, MD, FRCP(C), FAAN
Royalties or Patent Beneficiary: NMO-IgG
Consultant: Alexion, Chugai/Roche/Genentech, Mitsubishi Tanabe, Vielo Bio/Horizon
Speaker for Ineligible Company: Roche
Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com